First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 3.7142 GBX -0.95%
Updated: Apr 25, 2024

ROCE
Return on Capital Employed

-139%
Current
-58%
Average
-2.1%
Industry
Negative for the last year
-139%
Negative average
-58%
Worse than average
Worse than industry value

ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.

ROCE
-139%
=
EBIT
-3m
/
Capital Employed
1.3m

ROCE Across Competitors

ROCE Comparison
Fusion Antibodies PLC Competitors

Country Company Market Cap ROCE
UK
Fusion Antibodies PLC
LSE:FAB
3.5m GBP
-139%
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.2B USD
9%
US
Danaher Corp
NYSE:DHR
185.1B USD
7%
US
IQVIA Holdings Inc
NYSE:IQV
43.7B USD
10%
CH
Lonza Group AG
SIX:LONN
37.5B CHF
9%
KR
Samsung Biologics Co Ltd
KRX:207940
55.5T KRW
9%
US
Agilent Technologies Inc
NYSE:A
40.3B USD
14%
US
West Pharmaceutical Services Inc
NYSE:WST
28.4B USD
23%
US
Mettler-Toledo International Inc
NYSE:MTD
26.6B USD
48%
IE
ICON PLC
NASDAQ:ICLR
25.5B USD
7%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR
7%
Fusion Antibodies PLC
LSE:FAB
Country UK
Market Cap 3.5m GBP
ROCE
-139%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 223.2B USD
ROCE
9%
Danaher Corp
NYSE:DHR
Country US
Market Cap 185.1B USD
ROCE
7%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 43.7B USD
ROCE
10%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 37.5B CHF
ROCE
9%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.5T KRW
ROCE
9%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 40.3B USD
ROCE
14%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 28.4B USD
ROCE
23%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 26.6B USD
ROCE
48%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 25.5B USD
ROCE
7%
Sartorius Stedim Biotech SA
PAR:DIM
Country FR
Market Cap 19B EUR
ROCE
7%

Profitability Report

View the profitability report to see the full profitability analysis for Fusion Antibodies PLC.

Full Profitability Report

See Also

Summary
FAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
FAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FAB stock valuation using valuation multiples.
Wall Street Estimates
FAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Return on Capital Employed?

ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.

ROCE
-139%
=
EBIT
-3m
/
Capital Employed
1.3m
What is the ROCE of Fusion Antibodies PLC?

Based on Fusion Antibodies PLC's most recent financial statements, the company has ROCE of -139%.

ALPHA SPREAD
Join more than 131,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.